Joseph J. Larosa - 23 Mar 2023 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
EVP General Counsel and Secret
Signature
/s/** Joseph LaRosa
Issuer symbol
REGN
Transactions as of
23 Mar 2023
Net transactions value
-$2,700,020
Form type
4
Filing time
27 Mar 2023, 16:39:22 UTC
Previous filing
14 Mar 2023
Next filing
12 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $2,704,300 +10,000 +41% $270.43 34,213 23 Mar 2023 Direct
transaction REGN Common Stock Tax liability $5,404,320 -6,742 -20% $801.59 27,471 23 Mar 2023 Direct
holding REGN Common Stock 5,320 23 Mar 2023 2022 GRAT
holding REGN Common Stock 335 23 Mar 2023 By 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -10,000 -100% $0.000000* 0 23 Mar 2023 Common Stock 10,000 $270.43 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option award vests in four equal annual installments, commencing one year after the date of grant.